- Home
- ICLR vs EMN Comparison
ICLR vs EMN Comparison
Compare ICLR & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- EMN
- Stock Information
- Founded
- ICLR 1990
- EMN 1920
- Country
- ICLR Ireland
- EMN United States
- Employees
- ICLR N/A
- EMN N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- EMN Major Chemicals
- Sector
- ICLR Health Care
- EMN Industrials
- Exchange
- ICLR Nasdaq
- EMN Nasdaq
- Market Cap
- ICLR 11.4B
- EMN 9.2B
- IPO Year
- ICLR 1998
- EMN 1993
- Fundamental
- Price
- ICLR $128.72
- EMN $77.69
- Analyst Decision
- ICLR Buy
- EMN Buy
- Analyst Count
- ICLR 12
- EMN 13
- Target Price
- ICLR $204.18
- EMN $99.46
- AVG Volume (30 Days)
- ICLR 1.6M
- EMN 1.8M
- Earning Date
- ICLR 07-23-2025
- EMN 07-24-2025
- Dividend Yield
- ICLR N/A
- EMN 4.24%
- EPS Growth
- ICLR 11.53
- EMN 1.14
- EPS
- ICLR 9.19
- EMN 7.86
- Revenue
- ICLR $8,192,621,999.00
- EMN $9,362,000,000.00
- Revenue This Year
- ICLR N/A
- EMN N/A
- Revenue Next Year
- ICLR $2.34
- EMN $3.35
- P/E Ratio
- ICLR $14.18
- EMN $9.98
- Revenue Growth
- ICLR N/A
- EMN 2.79
- 52 Week Low
- ICLR $125.10
- EMN $70.90
- 52 Week High
- ICLR $347.72
- EMN $114.50
- Technical
- Relative Strength Index (RSI)
- ICLR 37.40
- EMN 41.34
- Support Level
- ICLR $127.96
- EMN $79.54
- Resistance Level
- ICLR $132.96
- EMN $82.83
- Average True Range (ATR)
- ICLR 4.04
- EMN 1.71
- MACD
- ICLR 0.75
- EMN -0.18
- Stochastic Oscillator
- ICLR 22.44
- EMN 0.47
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About EMN Eastman Chemical Company
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.